Editas Medicine

-$0.93 (-2.39%) Today
+$0.90 (+2.37%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.

About EDIT

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).

CEO
James C. Mullen
Employees
235
Headquarters
Cambridge, Massachusetts
Founded
2013

EDIT Key Statistics

Market Cap
2.60B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.71M
High Today
$39.48
Low Today
$37.86
Open Price
$39.34
Volume
955.44K
52 Week High
$99.95
52 Week Low
$27.12

EDIT News

Simply Wall St16h

Insiders in Editas Medicine, Inc. are down 18% on their US$1.4m purchase despite recent gains

Some of the losses seen by insiders who purchased US$1.4m worth of Editas Medicine, Inc. (NASDAQ:EDIT) shares over the past year were recovered after the stock

EDIT Earnings

-$1.00
-$0.63
-$0.25
$0.12
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure